Zetagen Therapeutics Secures 9.79 Million USD Series B Funding Raise for Advancement of ZetaMet™ and ZetaMAST™ for Treatment of Metastatic Bone and Soft Tissue Lesions
ZetaMet™ is a first-of-its kind molecular pathway designed to suspend cancer, inhibit pain, and regenerate bone. ZetaMet™ is presently in Phase 2a clinical trials for treatment of metastatic breast cancer lesions to bone as part of advanced stage cancer therapy.... Read More →
Scribe Biosciences Awarded a NIH Grant for High Throughput, Single-Cell Antibody Discovery
San Francisco, CA – August 10, 2023, Scribe Biosciences, a company developing technologies to study functional cell to cell interactions in a microenvironment, has announced it has received a NIH grant through the National Institute of Allergy and Infectious Disease... Read More →
RevBio Receives FDA Approval to Conduct its Second U.S.-Based Clinical Trial for Dental Implant Stabilization
RevBio has Developed a More Rapidly Resorbing Formulation of its Bone Adhesive Biomaterial for Implant Dentistry which will be Used in this Study LOWELL, Mass.–(BUSINESS WIRE)–RevBio, Inc., announced that it has received approval from the U.S. Food and Drug Administration... Read More →
Navi Closes $2.4 Million Round for its Breakthrough Medical Device
Navi is pleased to announce the successful completion of its latest funding round, securing a total of $2.4 million. Investors who took part in this round of funding included a $700,000 lead investment from $2 billion investment fund Breakthrough Victoria,... Read More →
RealSeq Secures Seed Financing to Advance the RiboMarkerTM Diagnostic Platform
Next Gen RNA fragmentomics-based diagnostics SANTA CRUZ, CALIFORNIA, UNITED STATES, July 27, 2023/EINPresswire.com/ — RealSeq Biosciences, Inc., a company developing RNA fragmentomics as real-time diagnostics for disease, today announced the close of its oversubscribed seed round. The investment allows RealSeq... Read More →
CellChorus joins NVIDIA Inception
Program nurtures startups revolutionizing industries with advancements in artificial intelligence HOUSTON, Texas — July 25, 2022 — CellChorus Inc. today announced it has joined NVIDIA Inception, a program designed to nurture startups revolutionizing industries with advancements in artificial intelligence (AI)... Read More →
Elemental Machines Appoints Edward Seguine As Chief Executive Officer
Elemental Machines, the pioneering developer of the comprehensive Intelligent Operations Platform for life sciences, has appointed Ed Seguine as Chief Executive Officer. Sridhar Iyengar, PhD, founder and incumbent CEO, will remain actively involved day-to-day as Chief Innovation Officer, leading the development of new... Read More →
Astellas and Eko Health Announce Agreement to Incorporate Next Generation Eko CORE 500™ Digital Stethoscope into Z1608, an Innovative Solution Under Development for Heart Failure Patients Built on Welldoc’s Proven Digital Therapeutic Platform
TOKYO, EMERYVILLE, Calif. and COLUMBIA, Md., July 18, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) and Eko Health Inc. (Co-Founder and CEO: Connor Landgraf, “Eko”) announced today that they have entered into a... Read More →
Major $148 million boost for 40 job-creating diversification projects featuring OncoRes Medical
The Cook Government is charging ahead with its plan to diversify Western Australia’s economy, with a massive $148 million funding injection to 40 innovative, job-creating projects across the State through its signature Investment Attraction Fund. Cook Government delivers on major... Read More →
NIH Awards Prenosis With Two Grants Totaling $4.8 million to Enable Precision Medicine for Sepsis
AI health tech company—developer of the world’s largest dataset and biobank for infection in acute care—will study the health states of suspected septic patients in hospitals CHICAGO, July 12, 2023 /PRNewswire/ — Prenosis, Inc., an artificial intelligence company enabling precision... Read More →